Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia (Q45055825)
Jump to navigation
Jump to search
scientific article published in October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia |
scientific article published in October 2004 |
Statements
1 reference
Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia (English)
1 reference
Claus Roehrborn
1 reference
Frans Debruyne
1 reference
Jack Barkin
1 reference
Peter van Erps
1 reference
Mario Reis
1 reference
Teuvo L J Tammela
1 reference
ARIA3001, ARIA3002 and ARIB3003 Study Investigators
1 reference
1 October 2004
1 reference
1 reference
46
1 reference
4
1 reference
488-94; discussion 495
1 reference
Identifiers
1 reference
1 reference